Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pharmacyclics Inc (PCYC) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pharmacyclics Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 949699.
Total stock buying since 2014: $0.
Total stock sales since 2014: $27,648,391.
Total stock option exercises since 2014: $5,448,648.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2015 | 0 | $0 | 57,514 | $14,618,684 | 202,209 | $2,547,798 |
| 2014 | 0 | $0 | 102,544 | $13,029,707 | 112,450 | $2,900,850 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2015-04 | 0 | $0 | 0 | $0 | 3,696 | $99,976 |
| 2015-03 | 0 | $0 | 57,514 | $14,618,684 | 198,513 | $2,447,822 |
| 2014-11 | 0 | $0 | 40,982 | $5,541,811 | 40,982 | $263,999 |
| 2014-09 | 0 | $0 | 12,000 | $1,463,440 | 12,000 | $27,599 |
| 2014-08 | 0 | $0 | 49,562 | $6,024,456 | 51,758 | $2,409,255 |
| 2014-05 | 0 | $0 | 0 | $0 | 7,710 | $199,997 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-04-13 | Tan Heow (Chief Quality&Tech Operations) | Option Ex | 3,696 | 27.05 | 99,976 |
| 2015-03-17 | Tan Heow (Chief Quality&Tech Operations) | Option Ex | 3,696 | 27.05 | 99,976 |
| 2015-03-13 | Soni Manmeet Singh (Chief Financial Officer) | Sale | 3,416 | 254.90 | 870,728 |
| 2015-03-12 | Zanganeh Maky (Chief Operating Officer) | Option Ex | 140,719 | 1.52 | 214,596 |
| 2015-03-11 | Soni Manmeet Singh (Chief Financial Officer) | Sale | 24,098 | 254.15 | 6,124,506 |
| 2015-03-11 | Soni Manmeet Singh (Chief Financial Officer) | Option Ex | 24,098 | 79.57 | 1,917,550 |
| 2015-03-11 | Zanganeh Maky (Chief Operating Officer) | Sale | 30,000 | 254.12 | 7,623,450 |
| 2015-03-11 | Zanganeh Maky (Chief Operating Officer) | Option Ex | 30,000 | 7.19 | 215,700 |
| 2014-11-13 | Soni Manmeet Singh (Chief Financial Officer) | Sale | 1,000 | 141.44 | 141,442 |
| 2014-11-13 | Soni Manmeet Singh (Chief Financial Officer) | Option Ex | 1,000 | 61.60 | 61,600 |
| 2014-11-13 | Fardis Maria (Chief of Oncology Ops & Allian) | Sale | 3,000 | 141.30 | 423,902 |
| 2014-11-13 | Fardis Maria (Chief of Oncology Ops & Allian) | Option Ex | 3,000 | 6.84 | 20,520 |
| 2014-11-12 | Zanganeh Maky (Chief Operating Officer) | Sale | 5,931 | 137.76 | 817,030 |
| 2014-11-12 | Zanganeh Maky (Chief Operating Officer) | Option Ex | 5,931 | 7.19 | 42,643 |
| 2014-11-10 | Love Richard B (General Counsel) | Sale | 1,500 | 133.87 | 200,805 |
| 2014-11-10 | Love Richard B (General Counsel) | Option Ex | 1,500 | 32.38 | 48,570 |
| 2014-11-10 | Zanganeh Maky (Chief Operating Officer) | Sale | 23,000 | 133.77 | 3,076,732 |
| 2014-11-10 | Zanganeh Maky (Chief Operating Officer) | Option Ex | 23,000 | 2.30 | 52,899 |
| 2014-11-07 | Fardis Maria (Chief of Oncology Ops & Allian) | Sale | 5,000 | 134.50 | 672,500 |
| 2014-11-07 | Fardis Maria (Chief of Oncology Ops & Allian) | Option Ex | 5,000 | 6.84 | 34,200 |
| 2014-11-07 | Zanganeh Maky (Chief Operating Officer) | Sale | 1,551 | 135.01 | 209,400 |
| 2014-11-07 | Zanganeh Maky (Chief Operating Officer) | Option Ex | 1,551 | 2.30 | 3,567 |
| 2014-09-04 | Zanganeh Maky (Chief Operating Officer) | Sale | 5,000 | 122.00 | 610,000 |
| 2014-09-04 | Zanganeh Maky (Chief Operating Officer) | Option Ex | 5,000 | 2.30 | 11,500 |
| 2014-09-03 | Zanganeh Maky (Chief Operating Officer) | Sale | 7,000 | 121.92 | 853,440 |
| 2014-09-03 | Zanganeh Maky (Chief Operating Officer) | Option Ex | 7,000 | 2.30 | 16,099 |
| 2014-08-27 | Love Richard B (General Counsel) | Sale | 1,500 | 124.00 | 186,000 |
| 2014-08-27 | Love Richard B (General Counsel) | Option Ex | 1,500 | 32.38 | 48,570 |
| 2014-08-21 | Tan Heow (Chief Quality&Tech Operations) | Option Ex | 2,196 | 27.05 | 59,401 |
| 2014-08-13 | Fardis Maria (Chief of Oncology Ops & Allian) | Sale | 4,000 | 121.01 | 484,040 |
| 2014-08-13 | Fardis Maria (Chief of Oncology Ops & Allian) | Option Ex | 4,000 | 6.84 | 27,360 |
| 2014-08-13 | Tan Heow (Chief Quality&Tech Operations) | Sale | 10,000 | 123.58 | 1,235,810 |
| 2014-08-13 | Tan Heow (Chief Quality&Tech Operations) | Option Ex | 10,000 | 27.05 | 270,500 |
| 2014-08-07 | Mcgreivy Jesse (Chief Medical Officer) | Sale | 34,062 | 120.92 | 4,118,606 |
| 2014-08-07 | Mcgreivy Jesse (Chief Medical Officer) | Option Ex | 34,062 | 58.82 | 2,003,424 |
| 2014-05-08 | Sjovall Boultbee Paula S (EVP, Sales and Marketing) | Option Ex | 7,710 | 25.94 | 199,997 |
Insider trading activities including stock purchases, stock sales, and option exercises of PCYC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pharmacyclics Inc (symbol PCYC, CIK number 949699) see the Securities and Exchange Commission (SEC) website.